Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial
- Submitting institution
-
University of Wolverhampton
- Unit of assessment
- 3 - Allied Health Professions, Dentistry, Nursing and Pharmacy
- Output identifier
- 1011
- Type
- D - Journal article
- DOI
-
10.1016/S0140-6736(18)32486-3
- Title of journal
- The Lancet
- Article number
- -
- First page
- 2353
- Volume
- 392
- Issue
- 10162
- ISSN
- 0140-6736
- Open access status
- Compliant
- Month of publication
- October
- Year of publication
- 2018
- URL
-
-
- Supplementary information
-
https://www.thelancet.com/cms/10.1016/S0140-6736(18)32486-3/attachment/20c2d10f-7890-48ab-abb8-e0bbef754c89/mmc1.pdf
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- Yes
- Number of additional authors
-
41
- Research group(s)
-
-
- Citation count
- 339
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- The author made a substantial contribution to the organisation of the conduct of the study and to analysis and interpretation of study data. The author helped critique the output for important intellectual content.
- Non-English
- No
- English abstract
- -